REQUEST A DEMO
Total
USD $0.00
Search more companies

Lek D.d. (Slovenia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Lek D.d. Profile Updated: November 24, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Lek is a pharmaceutical company specializing in the development and production of antibiotic drugs, pain relief medications, probiotics, and dietary supplements. Lek is a provider of similar biological drugs and operates in the pharmaceutical industry. The company claims to have a strong presence in the market and offers solutions for various health conditions.

Headquarters
57 Verovshkova Street
Ljubljana-Lek; Postal Code: 1526

Contact Details: Purchase the Lek D.d. report to view the information.

Website: http://www.lek.si

Basic Information
Total Employees:
Purchase the Lek D.d. report to view the information.
Outstanding Shares:
Purchase the Lek D.d. report to view the information.
Registered Capital:
Purchase the Lek D.d. report to view the information.
Financial Auditors:
Purchase the Lek D.d. report to view the information.
Incorporation Date:
1946
Key Executives
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Member of the Management Board
Purchase this report to view the information.
Member of the Management Board
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Doo Lek-ns Novi Sad - U Likvidaciji (Serbia)
100%
Sandoz D.d.
100%
Chnl D.o.o.
74.5%
Company Performance
Financial values in the chart are available after Lek D.d. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
20.94%
Total operating revenue
22.21%
Operating profit (EBIT)
15.47%
EBITDA
10.17%
Net Profit (Loss) for the Period
15.73%
Total assets
13.08%
Total equity
15.71%
Operating Profit Margin (ROS)
-0.42%
Net Profit Margin
-0.37%
Return on Equity (ROE)
0.01%
Debt to Equity Ratio
-1.56%
Quick Ratio
0.08%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?